Proprietary trading, often called "prop trading," occurs when a firm uses its own capital to trade stocks, bonds, currencies, commodities, and other financial instruments, rather than trading on behalf of clients and earning commission. Traders are provided with the firm's capital, and in return, they share a portion of the profits they generate. This model allows skilled traders to access significantly larger amounts of capital than they might have personally, potentially leading to greater profits.
For US-based traders, it's particularly important to choose a prop firm that is compliant with US regulations or has clear policies for engaging with US citizens. The regulatory environment can impact which firms are available and how they operate within the United States.
The dynamic environment of a trading floor, similar to the high-energy world prop traders engage in.
Several prop trading firms have distinguished themselves in catering to the needs of US traders. Below are some of the leading options as of May 2025, evaluated based on their funding programs, profit splits, supported platforms, tradable assets, and overall reputation within the US market.
DNA Funded consistently ranks as a top choice for US traders. It is lauded for its relatively low challenge fees, competitive trading conditions, and attractive profit splits that can reach up to 90%. The firm provides access to a vast range of over 800 tradable markets, including forex, indices, and stocks.
Modern trading platforms offer deep analytical tools, crucial for prop traders.
Funded Trading Plus is recognized for its instant funding options, particularly through its Master Trader Program, which grants immediate access to funded accounts upon successful evaluation. This makes it an attractive option for traders eager to start trading with firm capital quickly.
For traders focusing on futures, Topstep is a premier choice. Based in Chicago, this firm is well-regarded for its clear evaluation process, strong community support, and compliance with US regulations, making it a reliable partner for US futures traders.
FXIFY is emerging as a strong contender in the US prop trading scene, praised for its flexible trading rules and notably fast payout system. This focus on trader convenience and efficient profit withdrawal makes it appealing to active traders.
Blueberry Funded stands out for its affordable entry fees and flexible challenge options. It provides access to a wide range of markets, including forex and cryptocurrencies, making it a versatile choice for traders with diverse interests.
Beyond the firms detailed above, several others offer compelling features for US traders:
Offers low-cost challenges and profit splits up to 90%. Utilizes the ThinkTrader platform for US traders and is noted for transparent pricing and scaling opportunities.
Stands out by offering 100% profit splits for funded traders under certain conditions, along with scalable accounts.
Unique for its focus on options funding, also providing coaching for traders specializing in stocks or options. Limited to these asset classes.
Often recommended for forex traders, supporting MT5 and cTrader with substantial funding programs (up to $4 million) and attractive profit splits. A solid alternative given some global firms' limited US presence.
While a globally recognized top-tier firm with excellent coaching and resources, FTMO's direct availability to US traders has faced limitations due to regulatory reasons. US traders should verify current accessibility or alternative engagement methods if considering FTMO.
This radar chart provides a visual comparison of some of the top prop firms for US traders across several key attributes. Each axis represents a critical factor, with scores from 1 to 5 (where 5 is most favorable). This helps in quickly identifying firms that align best with your priorities, such as high profit potential, rapid funding, platform variety, diverse asset offerings, strong focus on US traders, and fair challenge conditions.
Selecting the right prop firm is a multifaceted decision. This mindmap outlines the key areas you should consider to ensure the firm aligns with your trading style, preferred assets, risk tolerance, capital goals, and platform preferences. Thinking through these interconnected factors will help you make a more informed choice.
To further aid your decision, this table provides a side-by-side comparison of key features for some of the prominent prop trading firms available to US traders. Note that specifics like maximum funding and profit splits can vary based on the chosen program within each firm.
Firm | Max Profit Split | Funding Model | Key Platforms | Primary Assets | US Availability | Typical Payout Speed |
---|---|---|---|---|---|---|
DNA Funded | Up to 90% | 1 or 2-step Evaluation | TradeLocker, DXTrade, MT4/5 | Forex, Indices, Stocks, Commodities | Yes | Fast (e.g., bi-weekly, some offer quicker options) |
Funded Trading Plus | Up to 90% (program dependent) | Evaluation; Instant Funding (Master Trader Program) | MT4, MT5, cTrader, DXTrade, Match-Trader | Forex, Futures, Indices, Crypto | Yes | 3-7 days |
Topstep | Up to 90% (100% on first $5k-$10k profit) | 1 or 2-step Evaluation ("Trading Combine") | NinjaTrader, TradingView, TSTrader, Quantower | Futures | Yes | Daily (after profit threshold reached) |
FXIFY | Up to 90% | 1 or 2-step Evaluation | MT4, MT5, cTrader | Forex, Indices, Crypto, Commodities | Yes | Fast (often on demand after initial period) |
Blueberry Funded | Up to 80% | 1 or 2-step Evaluation | MT4, MT5 | Forex, Crypto, Indices, Commodities | Yes | Bi-weekly |
ThinkCapital | Up to 90% | Evaluation Challenge | ThinkTrader | Forex, Indices, Commodities | Yes | Standard (e.g., monthly or bi-weekly) |
Funder Trading | Not specified, standard industry rates | Evaluation, Coaching provided | Proprietary or common stock/options platforms | Stocks, Options | Yes | Standard industry practice |
Selecting the right prop trading firm is a critical step. US traders should pay special attention to the following factors:
A supportive community and transparent firm practices are key for trader success.
Ensure the firm explicitly accepts US traders and understands the US regulatory environment. Some international firms may have restrictions or specific procedures for US clients.
Thoroughly understand the evaluation challenge. Key aspects include:
Profit splits typically range from 50% to 90% in favor of the trader. Higher splits are obviously better, but consider this in conjunction with other factors. Be aware of any ongoing fees or commissions once funded.
Firms vary in how quickly and frequently they process payouts. Options range from on-demand withdrawals to bi-weekly or monthly schedules. Look for firms with a proven track record of timely payouts.
The firm should support platforms you are comfortable with and that suit your trading style (e.g., MT4, MT5, cTrader, TradingView, NinjaTrader, or proprietary platforms). Access to quality data feeds, analytical tools, and reliable execution is paramount.
Confirm that the firm offers the markets you specialize in, whether it's forex, futures, stocks, indices, commodities, or cryptocurrencies. Some firms are specialists, while others offer a broader range.
Good customer support can be invaluable, especially when dealing with technical issues or account queries. Some firms also foster a community environment with forums, coaching, or performance analytics, which can be beneficial for trader development.
Hearing directly from other traders can provide valuable perspectives. The following video discusses some of the top prop firms often considered by US traders, offering insights that may help you in your selection process. It explores how to identify suitable firms based on various criteria relevant to traders in the United States.
This video, "Top 3 Prop Firms for US Traders REVEALED," delves into what makes certain prop firms stand out for traders based in the USA. It typically covers aspects like evaluation criteria, profit sharing, available trading platforms, and customer support, which are crucial for making an informed decision.